{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:03Z","timestamp":1786119243039,"version":"build-2736575974"},"publisher-location":"Berlin, Heidelberg","reference-count":66,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/82_2026_350","type":"book-chapter","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:41Z","timestamp":1786038521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted Modulation of Lipid Mediator-Biosynthetic Enzymes as Strategy for Inflammation Resolution Pharmacology"],"prefix":"10.1007","author":[{"given":"Paul M.","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"350_CR1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/11586800-000000000-00000","volume":"50","author":"M Abdel-Tawab","year":"2011","unstructured":"Abdel-Tawab M, Werz O, Schubert-Zsilavecz M (2011) Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet 50:349\u2013369","journal-title":"Clin Pharmacokinet"},{"key":"350_CR2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","volume":"1801","author":"G Bannenberg","year":"2010","unstructured":"Bannenberg G, Serhan CN (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim Biophys Acta 1801:1260\u20131273","journal-title":"Biochim Biophys Acta"},{"key":"350_CR3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/bj1760433","volume":"176","author":"RJ Bonney","year":"1978","unstructured":"Bonney RJ, Wightman PD, Davies P, Sadowski SJ, Kuehl FA Jr, Humes JL (1978) Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases by mouse peritoneal macrophages. Biochem J 176:433\u2013442","journal-title":"Biochem J"},{"key":"350_CR4","volume":"10","author":"F B\u00f6rner","year":"2023","unstructured":"B\u00f6rner F, Pace S, Jordan PM, Gerstmeier J, Gomez M, Rossi A, Gilbert NC, Newcomer ME, Werz O (2023) Allosteric activation of 15-lipoxygenase-1 by boswellic acid induces the lipid mediator class switch to promote resolution of inflammation. Adv Sci (Weinh) 10:E2205604","journal-title":"Adv Sci (Weinh)"},{"key":"350_CR5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1017\/S0029665113001031","volume":"72","author":"PC Calder","year":"2013","unstructured":"Calder PC (2013) N-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc 72:326\u2013336","journal-title":"Proc Nutr Soc"},{"key":"350_CR6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","volume":"1851","author":"PC Calder","year":"2015","unstructured":"Calder PC (2015) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851:469\u2013484","journal-title":"Biochim Biophys Acta"},{"key":"350_CR7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","volume":"64","author":"PC Calder","year":"2020","unstructured":"Calder PC (2020) Eicosanoids. Essays Biochem 64:423\u2013441","journal-title":"Essays Biochem"},{"key":"350_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101637","volume":"66","author":"EP Calderin","year":"2022","unstructured":"Calderin EP, Zheng JJ, Boyd NL, Mcnally L, Audam TN, Lorkiewicz P, Hill BG, Hellmann J (2022) Exercise-induced specialized proresolving mediators stimulate Ampk phosphorylation to promote mitochondrial respiration in macrophages. Mol Metab 66:101637","journal-title":"Mol Metab"},{"key":"350_CR9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","volume":"64","author":"N Chiang","year":"2020","unstructured":"Chiang N, Serhan CN (2020) Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 64:443\u2013462","journal-title":"Essays Biochem"},{"key":"350_CR10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","volume":"484","author":"N Chiang","year":"2012","unstructured":"Chiang N, Fredman G, B\u00e4ckhed F, Oh SF, Vickery T, Schmidt BA, Serhan CN (2012) Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484:524\u2013528","journal-title":"Nature"},{"key":"350_CR11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1219160","volume":"14","author":"P Dahlke","year":"2023","unstructured":"Dahlke P, Peltner LK, Jordan PM, Werz O (2023) Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators. Front Pharmacol 14:1219160","journal-title":"Front Pharmacol"},{"key":"350_CR12","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1182\/blood-2012-04-423525","volume":"120","author":"J Dalli","year":"2012","unstructured":"Dalli J, Serhan CN (2012) Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120:E60\u2013E72","journal-title":"Blood"},{"key":"350_CR13","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0001-2014","volume":"4","author":"J Dalli","year":"2016","unstructured":"Dalli J, Serhan C (2016) Macrophage proresolving mediators-the when and where. Microbiol Spectrum 4:10-1128","journal-title":"Microbiol Spectrum"},{"key":"350_CR14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nm.3911","volume":"21","author":"J Dalli","year":"2015","unstructured":"Dalli J, Chiang N, Serhan CN (2015) Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections. Nat Med 21:1071\u20131075","journal-title":"Nat Med"},{"key":"350_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","volume":"15","author":"EA Dennis","year":"2015","unstructured":"Dennis EA, Norris PC (2015) Eicosanoid storm in infection and inflammation. Nat Rev Immunol 15:511\u2013523","journal-title":"Nat Rev Immunol"},{"key":"350_CR16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41569-023-00984-x","volume":"21","author":"G Fredman","year":"2024","unstructured":"Fredman G, Serhan CN (2024) Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease. Nat Rev Cardiol 21:808\u2013823","journal-title":"Nat Rev Cardiol"},{"key":"350_CR17","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","volume":"294","author":"CD Funk","year":"2001","unstructured":"Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871\u20131875","journal-title":"Science"},{"key":"350_CR18","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, Miller AH, Mantovani A, Weyand CM, Barzilai N, Goronzy JJ, Rando TA, Effros RB, Lucia A, Kleinstreuer N, Slavich GM (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25:1822\u20131832","journal-title":"Nat Med"},{"key":"350_CR19","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1152\/japplphysiol.01004.2002","volume":"94","author":"S Gangemi","year":"2003","unstructured":"Gangemi S, Luciotti G, D\u2019Urbano E, Mallamace A, Santoro D, Bellinghieri G, Davi G, Romano M (2003) Physical exercise increases urinary excretion of Lipoxin A4 and related compounds. J Appl Physiol (1985) 94:2237\u20132240","journal-title":"J Appl Physiol (1985)"},{"key":"350_CR20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bcp.2019.03.003","volume":"165","author":"J Gerstmeier","year":"2019","unstructured":"Gerstmeier J, Kretzer C, Di Micco S, Miek L, Butschek H, Cantone V, Bilancia R, Rizza R, Troisi F, Cardullo N, Tringali C, Ialenti A, Rossi A, Bifulco G, Werz O, Pace S (2019a) Novel Benzoxanthene Lignans that favorably modulate lipid mediator biosynthesis: a promising pharmacological strategy for anti-inflammatory therapy. Biochem Pharmacol 165:263\u2013274","journal-title":"Biochem Pharmacol"},{"key":"350_CR21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00797","volume":"10","author":"J Gerstmeier","year":"2019","unstructured":"Gerstmeier J, Seegers J, Witt F, Waltenberger B, Temml V, Rollinger JM, Stuppner H, Koeberle A, Schuster D, Werz O (2019b) Ginkgolic acid is a multi-target inhibitor of key enzymes in pro-inflammatory lipid mediator biosynthesis. Front Pharmacol 10:797","journal-title":"Front Pharmacol"},{"key":"350_CR22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41589-020-0544-7","volume":"16","author":"NC Gilbert","year":"2020","unstructured":"Gilbert NC, Gerstmeier J, Schexnaydre EE, B\u00f6rner F, Garscha U, Neau DB, Werz O, Newcomer ME (2020) Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products. Nat Chem Biol 16:783\u2013790","journal-title":"Nat Chem Biol"},{"key":"350_CR23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114759","volume":"193","author":"NC Gilbert","year":"2021","unstructured":"Gilbert NC, Newcomer ME, Werz O (2021) Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: the Battle between pro- and anti-inflammatory lipid mediators. Biochem Pharmacol 193:114759","journal-title":"Biochem Pharmacol"},{"key":"350_CR24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","volume":"5","author":"DW Gilroy","year":"1999","unstructured":"Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5:698\u2013701","journal-title":"Nat Med"},{"key":"350_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2015.07.073","volume":"573","author":"I Ivanov","year":"2015","unstructured":"Ivanov I, Kuhn H, Heydeck D (2015) Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (Alox15). Gene 573:1\u201332","journal-title":"Gene"},{"key":"350_CR26","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1111\/febs.16266","volume":"289","author":"PM Jordan","year":"2022","unstructured":"Jordan PM, Werz O (2022) Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections. FEBS J 289:4212\u20134227","journal-title":"FEBS J"},{"key":"350_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108247","volume":"33","author":"PM Jordan","year":"2020","unstructured":"Jordan PM, Gerstmeier J, Pace S, Bilancia R, Rao Z, B\u00f6rner F, Miek L, Guti\u00e9rrez-Guti\u00e9rrez \u00d3, Arakandy V, Rossi A, Ialenti A, Gonz\u00e1lez-Est\u00e9vez C, L\u00f6ffler B, Tuchscherr L, Serhan CN, Werz O (2020) Staphylococcus aureus-derived \u0391-hemolysin evokes generation of specialized pro-resolving mediators promoting inflammation resolution. Cell Rep 33:108247","journal-title":"Cell Rep"},{"key":"350_CR28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/ph14111123","volume":"14","author":"PM Jordan","year":"2021","unstructured":"Jordan PM, Van Goethem E, M\u00fcller AM, Hemmer K, Gavioli V, Baillif V, Burmeister Y, Kr\u00f6mmelbein N, Dubourdeau M, Seilheimer B, Werz O (2021) The natural combination medicine Traumeel (Tr14) improves resolution of inflammation by promoting the biosynthesis of specialized pro-resolving mediators. Pharmaceuticals (Basel) 14:1123","journal-title":"Pharmaceuticals (Basel)"},{"key":"350_CR29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118190","volume":"188","author":"PM Jordan","year":"2025","unstructured":"Jordan PM, Peltner LK, Bachmann V, Dahlke P, Pace S, Thost L, H\u00f6rcher LC, Nischang V, Temml V, Rossi A, Werz O (2025) Uncovering anti-inflammatory natural products that synergize with supplemented Omega-3 Pufa for eliciting endogenous inflammation resolution signals. Biomed Pharmacother 188:118190","journal-title":"Biomed Pharmacother"},{"key":"350_CR30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2147\/JIR.S345510","volume":"15","author":"C Kretzer","year":"2022","unstructured":"Kretzer C, Jordan PM, Bilancia R, Rossi A, G\u00fcr Maz T, Banoglu E, Schubert US, Werz O (2022a) Shifting the biosynthesis of leukotrienes toward specialized pro-resolving mediators by the 5-lipoxygenase-activating protein (Flap) antagonist Brp-201. J Inflamm Res 15:911\u2013925","journal-title":"J Inflamm Res"},{"key":"350_CR31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114825","volume":"195","author":"C Kretzer","year":"2022","unstructured":"Kretzer C, Jordan PM, Meyer KPL, Hoff D, Werner M, Hofstetter RK, Koeberle A, Cala Peralta A, Viault G, Seraphin D, Richomme P, Helesbeux JJ, Stuppner H, Temml V, Schuster D, Werz O (2022b) Natural Chalcones elicit formation of specialized pro-resolving mediators and related 15-lipoxygenase products in human macrophages. Biochem Pharmacol 195:114825","journal-title":"Biochem Pharmacol"},{"key":"350_CR32","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","volume":"2","author":"BD Levy","year":"2001","unstructured":"Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2:612\u2013619","journal-title":"Nat Immunol"},{"key":"350_CR33","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1152\/ajpregu.00128.2013","volume":"305","author":"JF Markworth","year":"2013","unstructured":"Markworth JF, Vella L, Lingard BS, Tull DL, Rupasinghe TW, Sinclair AJ, Maddipati KR, Cameron-Smith D (2013) Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. Am J Physiol Regul Integr Comp Physiol 305:R1281\u2013R1296","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"350_CR34","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428\u2013435","journal-title":"Nature"},{"key":"350_CR35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/s-0042-103497","volume":"82","author":"J Meins","year":"2016","unstructured":"Meins J, Artaria C, Riva A, Morazzoni P, Schubert-Zsilavecz M, Abdel-Tawab M (2016) Survey on the quality of the top-selling European and American botanical dietary supplements containing Boswellic acids. Planta Med 82:573\u2013579","journal-title":"Planta Med"},{"key":"350_CR36","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/acs.jmedchem.5b01011","volume":"59","author":"H Meng","year":"2016","unstructured":"Meng H, Mcclendon CL, Dai Z, Li K, Zhang X, He S, Shang E, Liu Y, Lai L (2016) Discovery of novel 15-lipoxygenase activators to shift the human arachidonic acid metabolic network toward inflammation resolution. J Med Chem 59:4202\u20134209","journal-title":"J Med Chem"},{"key":"350_CR37","doi-asserted-by":"crossref","first-page":"14785","DOI":"10.1039\/C7CP08586A","volume":"20","author":"H Meng","year":"2018","unstructured":"Meng H, Dai Z, Zhang W, Liu Y, Lai L (2018) Molecular mechanism of 15-lipoxygenase allosteric activation and inhibition. Phys Chem Chem Phys 20:14785\u201314795","journal-title":"Phys Chem Chem Phys"},{"key":"350_CR38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cpt.980","volume":"104","author":"MP Motwani","year":"2018","unstructured":"Motwani MP, Bennett F, Norris PC, Maini AA, George MJ, Newson J, Henderson A, Hobbs AJ, Tepper M, White B, Serhan CN, Macallister R, Gilroy DW (2018) Potent anti-inflammatory and pro-resolving effects of Anabasum in a human model of self-resolving acute inflammation. Clin Pharmacol Ther 104:675\u2013686","journal-title":"Clin Pharmacol Ther"},{"key":"350_CR39","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","volume":"1","author":"P Nagarkatti","year":"2009","unstructured":"Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1:1333\u20131349","journal-title":"Future Med Chem"},{"key":"350_CR40","volume":"14","author":"V Nischang","year":"2023","unstructured":"Nischang V, Witt FM, B\u00f6rner F, Gomez M, Jordan PM, Werz O (2023) Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cells. Front Pharmacol 14:1332628","journal-title":"Front Pharmacol"},{"key":"350_CR41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157342","volume":"148","author":"V Nischang","year":"2025","unstructured":"Nischang V, Bachmann V, Perkowski BJ, M\u00f6bius P, B\u00f6rner F, Werner M, Gomez M, Abdel-Tawab M, Jordan PM, Werz O (2025) Boswellia serrata extract with low 3o-acetyl-11-keto-\u0392-boswellic acid-content causes efficient lipid mediator class switch. Phytomedicine 148:157342","journal-title":"Phytomedicine"},{"key":"350_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105556","volume":"167","author":"S Pace","year":"2021","unstructured":"Pace S, Zhang K, Jordan PM, Bilancia R, Wang W, B\u00f6rner F, Hofstetter RK, Potenza M, Kretzer C, Gerstmeier J, Fischer D, Lorkowski S, Gilbert NC, Newcomer ME, Rossi A, Chen X, Werz O (2021) Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators. Pharmacol Res 167:105556","journal-title":"Pharmacol Res"},{"key":"350_CR43","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.chembiol.2023.08.001","volume":"30","author":"LK Peltner","year":"2023","unstructured":"Peltner LK, Gluthmann L, B\u00f6rner F, Pace S, Hoffstetter RK, Kretzer C, Bilancia R, Pollastro F, Koeberle A, Appendino G, Rossi A, Newcomer ME, Gilbert NC, Werz O, Jordan PM (2023) Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators. Cell Chem Biol 30:1508\u20131524","journal-title":"Cell Chem Biol"},{"key":"350_CR44","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.3390\/nu15173848","volume":"15","author":"S Perez-Pinero","year":"2023","unstructured":"Perez-Pinero S, Munoz-Carrillo JC, Victoria-Montesinos D, Garcia-Munoz AM, Andreu-Caravaca L, Gomez M, Scholzel M, Garcia-Guillen AI, Lopez-Roman FJ (2023) Efficacy of Boswellia serrata extract and\/or an omega-3-based product for improving pain and function in people older than 40 years with persistent knee pain: a randomized double-blind controlled clinical trial. Nutrients 15:3848","journal-title":"Nutrients"},{"key":"350_CR45","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100097","volume":"77","author":"M Perretti","year":"2025","unstructured":"Perretti M, Montero-Melendez T (2025) Resolution pharmacology: state-of-the-art and therapeutic landscape. Pharmacol Rev 77:100097","journal-title":"Pharmacol Rev"},{"key":"350_CR46","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","volume":"36","author":"M Perretti","year":"2015","unstructured":"Perretti M, Leroy X, Bland EJ, Montero-Melendez T (2015) Resolution pharmacology: opportunities for therapeutic innovation in inflammation. Trends Pharmacol Sci 36:737\u2013755","journal-title":"Trends Pharmacol Sci"},{"key":"350_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115210","volume":"204","author":"O Radmark","year":"2022","unstructured":"Radmark O (2022) Formation of eicosanoids and other oxylipins in human macrophages. Biochem Pharmacol 204:115210","journal-title":"Biochem Pharmacol"},{"key":"350_CR48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","volume":"1851","author":"O R\u00e5dmark","year":"2015","unstructured":"R\u00e5dmark O, Werz O, Steinhilber D, Samuelsson B (2015) 5-lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim Biophys Acta 1851:331\u2013339","journal-title":"Biochim Biophys Acta"},{"key":"350_CR49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/1-4020-5688-5_1","volume":"42","author":"KD Rainsford","year":"2007","unstructured":"Rainsford KD (2007) Anti-inflammatory drugs in the 21st century. Subcell Biochem 42:3\u201327","journal-title":"Subcell Biochem"},{"key":"350_CR50","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1073\/pnas.77.8.4928","volume":"77","author":"CA Rouzer","year":"1980","unstructured":"Rouzer CA, Scott WA, Cohn ZA, Blackburn P, Manning JM (1980) Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus. Proc Natl Acad Sci USA 77:4928\u20134932","journal-title":"Proc Natl Acad Sci USA"},{"key":"350_CR51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.838782","volume":"13","author":"NH Schebb","year":"2022","unstructured":"Schebb NH, K\u00fchn H, Kahnt AS, Rund KM, O\u2019Donnell VB, Flamand N, Peters-Golden M, Jakobsson PJ, Weylandt KH, Rohwer N, Murphy RC, Geisslinger G, Fitzgerald GA, Hanson J, Dahlgren C, Alnouri MW, Offermanns S, Steinhilber D (2022) Formation, signaling and occurrence of specialized pro-resolving lipid mediators-what is the evidence so far? Front Pharmacol 13:838782","journal-title":"Front Pharmacol"},{"key":"350_CR52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510:92\u2013101","journal-title":"Nature"},{"key":"350_CR53","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","volume":"128","author":"CN Serhan","year":"2018","unstructured":"Serhan CN, Levy BD (2018) Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 128:2657\u20132669","journal-title":"J Clin Invest"},{"key":"350_CR54","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6:1191\u20131197","journal-title":"Nat Immunol"},{"key":"350_CR55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1096\/fj.06-7227rev","volume":"21","author":"CN Serhan","year":"2007","unstructured":"Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O\u2019Neill LA, Perretti M, Rossi AG, Wallace JL (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325\u2013332","journal-title":"FASEB J"},{"key":"350_CR56","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/cas.13380","volume":"108","author":"R Shintoku","year":"2017","unstructured":"Shintoku R, Takigawa Y, Yamada K, Kubota C, Yoshimoto Y, Takeuchi T, Koshiishi I, Torii S (2017) Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by Erastin and Rsl3. Cancer Sci 108:2187\u20132194","journal-title":"Cancer Sci"},{"key":"350_CR57","doi-asserted-by":"crossref","first-page":"E0242543","DOI":"10.1371\/journal.pone.0242543","volume":"15","author":"A Sobrino","year":"2020","unstructured":"Sobrino A, Walker ME, Colas RA, Dalli J (2020) Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators. PLoS One 15:E0242543","journal-title":"PLoS One"},{"key":"350_CR58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","volume":"339","author":"I Tabas","year":"2013","unstructured":"Tabas I, Glass CK (2013) Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339:166\u2013172","journal-title":"Science"},{"key":"350_CR59","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.apsb.2021.04.011","volume":"11","author":"TT Van Anh","year":"2021","unstructured":"Van Anh TT, Mostafa A, Rao Z, Pace S, Schwaiger S, Kretzer C, Temml V, Giesel C, Jordan PM, Bilancia R, Weinigel C, Rummler S, Waltenberger B, Hung T, Rossi A, Stuppner H, Werz O, Koeberle A (2021) From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolution. Acta Pharm Sin B 11:1629\u20131647","journal-title":"Acta Pharm Sin B"},{"key":"350_CR60","doi-asserted-by":"crossref","first-page":"43169","DOI":"10.1021\/acsomega.2c05877","volume":"7","author":"C Van Hoorebeke","year":"2022","unstructured":"Van Hoorebeke C, Yang K, Mussetter SJ, Koch G, Rutz N, Lokey RS, Crews P, Holman TR (2022) Reevaluation of a bicyclic pyrazoline as a selective 15-lipoxygenase V-type activator possessing fatty acid specificity. ACS Omega 7:43169\u201343179","journal-title":"ACS Omega"},{"key":"350_CR61","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1515\/hsz-2018-0472","volume":"400","author":"G Von Hoven","year":"2019","unstructured":"Von Hoven G, Qin Q, Neukirch C, Husmann M, Hellmann N (2019) Staphylococcus aureus \u0391-toxin: small pore, large consequences. Biol Chem 400:1261\u20131276","journal-title":"Biol Chem"},{"key":"350_CR62","volume":"2018","author":"J Wang","year":"2018","unstructured":"Wang J, Chen N, Fang L, Feng Z, Li G, Mucelli A, Zhang X, Zhou X (2018) A systematic review about the efficacy and safety of Tripterygium wilfordii Hook.F. preparations used for the management of rheumatoid arthritis. Evid Based Complement Alternat Med 2018:1567463","journal-title":"Evid Based Complement Alternat Med"},{"key":"350_CR63","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1096\/fj.201802509R","volume":"33","author":"M Werner","year":"2019","unstructured":"Werner M, Jordan PM, Romp E, Czapka A, Rao Z, Kretzer C, Koeberle A, Garscha U, Pace S, Claesson HE, Serhan CN, Werz O, Gerstmeier J (2019) Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome. FASEB J 33:6140\u20136153","journal-title":"FASEB J"},{"key":"350_CR64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41467-017-02538-5","volume":"9","author":"O Werz","year":"2018","unstructured":"Werz O, Gerstmeier J, Libreros S, De La Rosa X, Werner M, Norris PC, Chiang N, Serhan CN (2018) Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity. Nat Commun 9:59","journal-title":"Nat Commun"},{"key":"350_CR65","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/biom11050746","volume":"11","author":"K Zhang","year":"2021","unstructured":"Zhang K, Pace S, Jordan PM, Peltner LK, Weber A, Fischer D, Hofstetter RK, Chen X, Werz O (2021) Beneficial modulation of lipid mediator biosynthesis in innate immune cells by antirheumatic Tripterygium wilfordii glycosides. Biomolecules 11:746","journal-title":"Biomolecules"},{"key":"350_CR66","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.4049\/jimmunol.1900144","volume":"203","author":"JJ Zheng","year":"2019","unstructured":"Zheng JJ, Pena Calderin E, Hill BG, Bhatnagar A, Hellmann J (2019) Exercise promotes resolution of acute inflammation by catecholamine-mediated stimulation of resolvin D1 biosynthesis. J Immunol 203:3013\u20133022","journal-title":"J Immunol"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2026_350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:49Z","timestamp":1786038529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2026_350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/82_2026_350","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"7 August 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"This chapter is a review of previously published accounts; as such, no animal or human studies were performed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This work was supported by the Deutsche Forschungsgemeinschaft, SFB 1127\/3 ChemBioSys 239748522 project A04 and SFB1278\/2 Polytarget 316213987 project A04 and C02 (to O.W.). We also thank the Free State of Thuringia\/Th\u00fcringer Aufbaubank and the European Union\/Europ\u00e4ischer Fonds f\u00fcr regionale Entwicklung (2023FGR0077 \u201cnature4HEALTH\u201d).","order":2,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare they have no conflict of interest.","order":3,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}